This Peptide Reduced Visceral Fat by 15% in Human Trials @nicknorwitzMDPhD
This Peptide Reduced Visceral Fat by 15% in Human Trials  @nicknorwitzMDPhD
Uploaded April 2026 | Updated November 2026, 10 hours ago
For the written breakdown, early access to information like this, and extra nuances, see the associated StayCurious Metabolism Newsletter: open.substack.com/pub/staycuriousmetabolism/p/the-peptide-proven-to-reduce-visceral?r=40ekz2&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true
A peptide called tesamorelin has been shown in multiple randomized controlled trials to reduce visceral fat—the type of fat linked to inflammation and cardiometabolic disease. It works by mimicking growth hormone–releasing hormone, stimulating the body’s own growth hormone production. In one study, 6 months of treatment led to a ~15% reduction in visceral fat compared to placebo. For the full mechanisms, limitations, and nuance, watch the long-form breakdown linked above.

#VisceralFat #MetabolicHealth #Hormones #GrowthHormone #FatLossScience #ClinicalTrials #StayCurious
This Peptide Reduced Visceral Fat by 15% in Human TrialsThis Tiny Peptide Might 2X REM Sleep!I Changed My Mind on Cholesterol Medications (After 7 Years)Healthy Things That Are Really Unhealthy5 Things You Need to Know About Lp(a) and Heart Health
Nick Norwitz MD PhD |

This Peptide Reduced Visceral Fat by 15% in Human Trials

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER